| Panel testing for familial breast cancer: calibrating the tension between research and clinical care ER Thompson, SM Rowley, N Li, S McInerny, L Devereux, ... J Clin Oncol 34 (13), 1455-1459, 2016 | 214 | 2016 |
| miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition C Sun, N Li, Z Yang, B Zhou, Y He, D Weng, Y Fang, P Wu, P Chen, ... Journal of the National Cancer Institute 105 (22), 1750-1758, 2013 | 187 | 2013 |
| Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype JE Grolleman, RM De Voer, FA Elsayed, M Nielsen, RDA Weren, C Palles, ... Cancer cell 35 (2), 256-266. e5, 2019 | 178 | 2019 |
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ... Journal of medical genetics 53 (5), 298-309, 2016 | 141 | 2016 |
| The biodiversity composition of microbiome in ovarian carcinoma patients B Zhou, C Sun, J Huang, M Xia, E Guo, N Li, H Lu, W Shan, Y Wu, Y Li, ... Scientific reports 9 (1), 1-11, 2019 | 134 | 2019 |
| The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis C Sun, N Li, D Ding, D Weng, L Meng, G Chen, D Ma PloS one 9 (5), e95285, 2014 | 130 | 2014 |
| Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways B Zhou, C Sun, N Li, W Shan, H Lu, L Guo, E Guo, M Xia, D Weng, ... International journal of oncology 48 (5), 2087-2097, 2016 | 96 | 2016 |
| Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer N Li, C Sun, B Zhou, H Xing, D Ma, G Chen, D Weng PLoS One 9 (7), e100314, 2014 | 94 | 2014 |
| Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis C Sun, G Chen, Z Yang, J Jiang, X Yang, N Li, B Zhou, T Zhu, J Wei, ... Fertility and sterility 100 (3), 782-787. e5, 2013 | 93 | 2013 |
| Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility SM Rowley, L Mascarenhas, L Devereux, N Li, KC Amarasinghe, ... Genetics in Medicine 21 (4), 913-922, 2019 | 77 | 2019 |
| MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis C Sun, X Li, E Guo, N Li, B Zhou, H Lu, J Huang, M Xia, W Shan, B Wang, ... Oncogene 39 (8), 1681-1695, 2020 | 68 | 2020 |
| miR‑222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1 C Sun, NA Li, BO Zhou, Z Yang, D Ding, D Weng, L Meng, S Wang, ... Oncology letters 6 (2), 507-512, 2013 | 65 | 2013 |
| Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity P Lobachevsky, T Leong, P Daly, J Smith, N Best, J Tomaszewski, ... Cancer letters 383 (2), 212-219, 2016 | 55 | 2016 |
| Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls ER Thompson, KL Gorringe, SM Rowley, MW Wong-Brown, S McInerny, ... Breast Cancer Research 17 (1), 1-11, 2015 | 51 | 2015 |
| Reevaluation of the BRCA2 truncating allele c. 9976A> T (p. Lys3326Ter) in a familial breast cancer context ER Thompson, KL Gorringe, SM Rowley, N Li, S McInerny, ... Scientific reports 5 (1), 1-6, 2015 | 49 | 2015 |
| Molecular analysis of PALB2‐associated breast cancers JEA Lee, N Li, SM Rowley, D Cheasley, M Zethoven, S McInerny, ... The Journal of pathology 245 (1), 53-60, 2018 | 48 | 2018 |
| Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice J Huang, W Shan, N Li, B Zhou, E Guo, M Xia, H Lu, Y Wu, J Chen, ... Reproductive BioMedicine Online 42 (3), 505-519, 2021 | 43 | 2021 |
| Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer N Li, S McInerny, M Zethoven, D Cheasley, BWX Lim, SM Rowley, ... JNCI: Journal of the National Cancer Institute 111 (12), 1332-1338, 2019 | 43 | 2019 |
| Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer B Zhou, H Xu, M Xia, C Sun, N Li, E Guo, L Guo, W Shan, H Lu, Y Wu, Y Li, ... Frontiers of medicine 11 (2), 214-222, 2017 | 42 | 2017 |
| Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs N Li, SM Rowley, ER Thompson, S McInerny, L Devereux, ... Breast Cancer Research 20 (1), 1-11, 2018 | 37 | 2018 |
chaoyang sunMD Anderson Cancer CenterVerifierad e-postadress på smail.hust.edu.cn
